51 studies found for:    Open Studies | "Spondylitis, Ankylosing"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
2 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
3 Unknown  Clinical and Radiographic Correlation of Ultrasound MASEI Index in Patients With Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
4 Not yet recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: Secukinumab;   Biological: Placebo
5 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
6 Recruiting BI 655066 Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
Condition: Spondylitis, Ankylosing
Interventions: Drug: Placebo;   Drug: BI 655066
7 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
8 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
9 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
10 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
11 Recruiting Biologic Rheumatology Registry Across Canada
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic
Intervention:
12 Recruiting Extension in AS: Sustainability of Benefits, Safety and Tolerability
Condition: Spondylitis, Ankylosing
Intervention: Biological: Secukinumab
13 Not yet recruiting A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
14 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
15 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
16 Unknown  Prednisolone in Active Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: prednisolone
17 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
18 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
19 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
20 Recruiting Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
Condition: Ankylosing Spondylitis
Interventions: Drug: Adalimumab;   Drug: Methotrexate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years